Skip to content

Guardian Pharmacy Services

US · GRDN #2584 by market cap Listed 2024
40.68 -0.52 -1.26%
Live - 5344 symbols - heartbeat 61s ago · 2026-10-07 19:54
After-hours 40.68 0.00%
Market cap
2.58B
P/B
10.49
EPS
0.78
Reader sentiment Are you bullish or bearish on GRDN?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    Analysts Offer Insights on NA Companies: Emerson Electric Company (EMR), Omada Health, Inc. (OMDA) and Guardian Pharmacy Services, Inc. Class A (GRDN)
    TipRanks · 2026/8/7
  • Rating change
    Oppenheimer Maintains Guardian Pharmacy Services(GRDN.US) With Buy Rating, Raises Target Price to $49
    Market Newswire · 2026/8/7
  • Earnings Flash (GRDN) Guardian Pharmacy Services, Inc. Reports Q2 Revenue $351.8M, Vs. FactSet Est of $340.4M
    MT Newswires · 2026/8/7
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Guardian Pharmacy Services, Inc. Class A (GRDN) and Alto Neuroscience, Inc. (ANRO)
    TipRanks · 2026/6/17
  • Rating change
    Stephens Remains a Buy on Guardian Pharmacy Services, Inc. Class A (GRDN)
    TipRanks · 2026/8/7
  • Rating change
    Stephens Keeps Their Buy Rating on Guardian Pharmacy Services, Inc. Class A (GRDN)
    TipRanks · 2026/6/23
  • Rating change
    Truist Financial Maintains Guardian Pharmacy Services(GRDN.US) With Buy Rating, Raises Target Price to $47
    Market Newswire · 2026/6/17
  • Truist Financial Maintains Guardian Pharmacy Services(GRDN.US) With Buy Rating, Announces Target Price $51
    Market Newswire · 2026/9/21
  • Rating change
    Oppenheimer Sticks to Its Buy Rating for Guardian Pharmacy Services, Inc. Class A (GRDN)
    TipRanks · 2026/8/7
  • Rating change
    Truist Financial Maintains Guardian Pharmacy Services(GRDN.US) With Buy Rating
    Market Newswire · 2026/8/7
  • Rating change
    Truist Financial Sticks to Their Buy Rating for Guardian Pharmacy Services, Inc. Class A (GRDN)
    TipRanks · 2026/6/23
  • Rating change
    BofA Securities Maintains Guardian Pharmacy Services(GRDN.US) With Buy Rating, Announces Target Price $47
    Market Newswire · 2026/8/7
  • Rating change
    BofA Securities Maintains Guardian Pharmacy Services(GRDN.US) With Buy Rating
    Market Newswire · 2026/7/2
  • Rating change
    Analysts Are Bullish on These Healthcare Stocks: Amylyx Pharmaceuticals Inc (AMLX), Guardian Pharmacy Services, Inc. Class A (GRDN)
    TipRanks · 2026/7/2
  • Rating change
    Analysts' Top Healthcare Picks: Diamedica Therapeutics (DMAC), Guardian Pharmacy Services, Inc. Class A (GRDN)
    TipRanks · 2026/6/23
  • Analysts Conflicted on These NA Names: Starz Entertainment Corp (STRZ), Guardian Pharmacy Services, Inc. Class A (GRDN) and MSC Income Fund, Inc. (MSIF)
    TipRanks · 2026/8/8
  • Rating change
    BofA Securities Maintains Guardian Pharmacy Services(GRDN.US) With Buy Rating, Raises Target Price to $47
    Market Newswire · 2026/6/17
  • KeyBanc Initiates Guardian Pharmacy Services(GRDN.US) With Buy Rating, Announces Target Price $52
    Market Newswire · 2026/9/23
  • Rating change
    Truist Financial Initiates Guardian Pharmacy Services(GRDN.US) With Buy Rating, Announces Target Price $47
    Market Newswire · 2026/6/23
  • BofA Securities Maintains Guardian Pharmacy Services(GRDN.US) With Buy Rating, Maintains Target Price $47
    Market Newswire · 2026/9/2

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.